Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q4 2017 call → NOWe need to determine if the transcript shows management's account of the just-reported period (Q4 fiscal 2017) is built around real business activity that crossed from not-happening to happening partway through the period or around its edges, and that management makes clear this newly started activity is still completing its climb, so the period's reported numbers average the 'before' and 'after' and sit below the level at which the business is already running. We need to look for concrete starts that began during or around the period, described in language of crossing over, and that the climb is incomplete, with the reported numbers lagging. From the transcript, several things are mentioned: - New products launched: e.g., Brevera (real-time biopsy system) launched, MyoSure MANUAL launched, 3Dimensions and 3D Performance systems, Panther Fusion received FDA clearance for first two respiratory assays, submental indication for SculpSure approved at end of quarter, RF platform expected in early calendar 2018 (not yet launched). - The Panther Fusion: "we received FDA clearance for the first two respiratory assays that will run on our revolutionary new Panther Fusion system." That is a clearance, not necessarily sales yet. They said "we won't have any impact this year on Fusion on the flu season. It just came a little bit late and we still have one more assay that we want to prove." So it's not yet contributing meaningfully. - Brevera: "we also launched Brevera, our revolutionary new real-time biopsy system, which should contribute to growth in 2018." That is a launch, but it's not clear if it started selling in the quarter? They said "launched" and "should contribute to growth in 2018" - so it's a start, but the contribution is future. Also, it's not clear if it's a major part of the period's story. - MyoSure MANUAL: "we recently launched MyoSure MANUAL" - again, a launch, but not clear if it's central. - Cynosure: They talk about new leadership, new sales reps, but that's not a product start.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.